ClinicalTrials.Veeva

Menu

Angelman Syndrome Natural History Study

Boston Children's Hospital logo

Boston Children's Hospital

Status

Enrolling

Conditions

Angelman Syndrome

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT04507997
IRB-P00025249

Details and patient eligibility

About

The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.

Full description

The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ultimately improving the care of individuals with Angelman syndrome.

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Molecular diagnosis of Angelman syndrome

Exclusion criteria

  • Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment

Trial contacts and locations

12

Loading...

Central trial contact

Wen-Hann Tan, BMBS; Batsheva Friedman, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems